| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
35,445 |
31,653 |
$2.47M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,875 |
3,647 |
$411K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
9,177 |
8,636 |
$397K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
14,855 |
14,667 |
$376K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
4,640 |
4,635 |
$349K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
4,453 |
4,441 |
$331K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
3,001 |
2,997 |
$248K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
3,560 |
3,403 |
$238K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
18,377 |
17,910 |
$117K |
| 90461 |
|
4,146 |
4,125 |
$116K |
| 92551 |
|
9,013 |
9,008 |
$88K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
690 |
690 |
$61K |
| 97802 |
|
7,328 |
7,259 |
$56K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,066 |
1,048 |
$42K |
| 99401 |
|
2,189 |
2,039 |
$33K |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
3,253 |
3,252 |
$25K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
3,213 |
3,212 |
$16K |
| 90697 |
|
281 |
281 |
$16K |
| 0002A |
|
450 |
447 |
$15K |
| 0001A |
|
440 |
437 |
$15K |
| 36415 |
Collection of venous blood by venipuncture |
13,891 |
13,372 |
$14K |
| 99173 |
|
8,482 |
8,464 |
$12K |
| 99050 |
|
1,393 |
1,306 |
$11K |
| 96127 |
|
5,575 |
5,510 |
$9K |
| 0071A |
|
245 |
244 |
$9K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
111 |
110 |
$9K |
| 0072A |
|
238 |
238 |
$9K |
| 99381 |
|
118 |
118 |
$7K |
| 87110 |
|
705 |
705 |
$6K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
284 |
273 |
$6K |
| 90688 |
|
2,629 |
2,622 |
$6K |
| S9451 |
Exercise classes, non-physician provider, per session |
4,364 |
4,204 |
$5K |
| 99051 |
|
998 |
960 |
$3K |
| 99383 |
|
43 |
43 |
$3K |
| 90670 |
|
1,461 |
1,460 |
$3K |
| 86580 |
|
427 |
422 |
$3K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
115 |
113 |
$3K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
20 |
20 |
$2K |
| 99406 |
|
2,262 |
2,261 |
$2K |
| 99384 |
|
26 |
26 |
$2K |
| 0004A |
|
43 |
43 |
$2K |
| 90715 |
|
237 |
237 |
$1K |
| 99382 |
|
15 |
15 |
$1K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
151 |
151 |
$1K |
| 96161 |
|
1,270 |
1,152 |
$931.58 |
| 36400 |
|
126 |
124 |
$903.66 |
| 86703 |
|
128 |
127 |
$853.14 |
| 99441 |
|
28 |
22 |
$843.00 |
| 90651 |
|
80 |
80 |
$706.98 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
3,787 |
3,774 |
$684.00 |
| 97803 |
|
517 |
516 |
$653.72 |
| 90716 |
|
134 |
133 |
$634.21 |
| 99188 |
|
52 |
52 |
$587.28 |
| 87592 |
|
230 |
230 |
$567.76 |
| 90723 |
|
608 |
607 |
$500.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
32 |
31 |
$482.56 |
| 90707 |
|
112 |
112 |
$343.08 |
| 94760 |
|
570 |
543 |
$327.87 |
| 90686 |
|
342 |
342 |
$305.82 |
| 36406 |
|
84 |
82 |
$297.21 |
| 99000 |
|
6,076 |
5,761 |
$254.88 |
| 90648 |
|
363 |
362 |
$250.00 |
| 90734 |
|
344 |
344 |
$244.47 |
| 90633 |
|
689 |
689 |
$205.81 |
| 87081 |
|
128 |
128 |
$181.70 |
| 94664 |
|
13 |
13 |
$166.48 |
| 87070 |
|
13 |
12 |
$87.26 |
| 98960 |
|
13 |
13 |
$83.01 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
5,396 |
5,370 |
$72.00 |
| 90656 |
|
79 |
79 |
$45.88 |
| 96160 |
|
13 |
13 |
$16.18 |
| 91307 |
|
406 |
378 |
$1.57 |
| 91300 |
|
621 |
559 |
$1.07 |
| 90710 |
|
142 |
142 |
$0.00 |
| 90681 |
|
137 |
137 |
$0.00 |
| 99072 |
|
2,299 |
2,110 |
$0.00 |
| 90685 |
|
45 |
45 |
$0.00 |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
20 |
18 |
$0.00 |
| 3008F |
|
8,732 |
8,670 |
$0.00 |
| 90680 |
|
642 |
641 |
$0.00 |
| 90696 |
|
71 |
71 |
$0.00 |
| 90698 |
|
234 |
234 |
$0.00 |
| 1036F |
|
34 |
34 |
$0.00 |
| G8418 |
Bmi is documented below normal parameters and a follow-up plan is documented |
40 |
40 |
$0.00 |